Keywords = SARS-CoV-2
Unleashing Monoclonal Antibodies: Targeting Covid-19’s Nucleocapsid Protein and Spike Antigens

Articles in Press, Accepted Manuscript, Available Online from 28 September 2024

10.22092/ari.2024.365665.3118

Rasool Madani; Fariba Golchinfar; Mahsa Hezarosi; Tara Emami; Arash Ghanizade


Development of an ELISA for SARS-CoV-2 Detection focusing on antibodies against nucleocapsid protein

Articles in Press, Accepted Manuscript, Available Online from 28 September 2024

10.22092/ari.2024.366081.3188

Fariba Golchinfar; Rasool Madani; Mahsa Hezarosi; Tara Emami; Arash Ghanizade


Manufacturing Technology and Effectiveness of Corona Vaccines: A Bibliometric Review

Articles in Press, Accepted Manuscript, Available Online from 09 October 2024

10.22092/ari.2024.365795.3143

Sara Rashki Ghalenoo; Mahboobeh Talebi Mehrdar; Khadijeh Saravan; Narjes Dahmardeh; Zeynab Bayat; Mehdi Hassanshahian


Serological Studies of IgG and IgM in Response to SARS-CoV-2 Vaccination in Erbil, Kurdistan-Iraq

Articles in Press, Accepted Manuscript, Available Online from 11 November 2024

10.22092/ari.2024.366171.3199

Mohammed Yousif Merza


COVID-19 and ACE2 receptor in different tissues: From pathophysiologic function to therapeutic responses

Articles in Press, Accepted Manuscript, Available Online from 11 November 2024

10.22092/ari.2024.366020.3177

Mohammad Karimian; Mohaddeseh Behjati; Amir Hossein Mohammadi


Development of a Novel Indirect ELISA Assay for the Detection of SARS-CoV-2 IgG antibodies using a Highly sensitive RBD-Nucleoprotein Fusion Antigen

Articles in Press, Accepted Manuscript, Available Online from 11 November 2024

10.22092/ari.2024.365446.3084

Sohrab - Sam; Behrokh - Farahmand; Hamideh Ofoghi


Safflower-derived cationic lipid nanoparticles: potential impact on the delivery of SARS-CoV-2 mRNA transcripts

Volume 79, Issue 6, November and December 2024, Pages 1217-1226

10.32592/ARI.2024.79.6.1217

Shahla Shahsavandi; Hadi Nasr Isfahani; Amir Ali Hariri; Zarrin Sharifnia; Sina Soleimani; Abolfazl Moradi


Effectiveness of vaccination (Sinopharm) among Covid-19 positive patients in a tertiary care hospital

Volume 79, Issue 5, September and October 2024, Pages 967-972

10.32592/ARI.2024.79.5.967

Muhammad Nadeem; Naveed Arshad; Muhammad Aurang Zeb; Sumaira Mushtaq; Shazia Siddiq; Jahangir Zeb


Use of Tranexamic Acid in SARS-COV-2: Boon or Bane?

Volume 79, Issue 3, May and June 2024, Pages 459-464

10.32592/ARI.2024.79.3.459

Manisha Chandela; Ashok Saxena; RK Mehta; Sandip Mohanty; Pretty Singla; Aarushi Solanki; Sumit Jethani; bhushan dattatray kamble


Seroprevalence of Anti-SARS-CoV-2 IgG and IgM Antibodies among Government Employees in Iran

Volume 78, Issue 5, September and October 2023, Pages 1413-1420

10.32592/ARI.2023.78.5.1413

Mohammad Hossein Zabeh Jazi; Mehran Dabaghian


Role of Serum Ferritin, D-Dimer, and C-Reactive Protein Parameters in COVID 19 Severity

Volume 78, Issue 2, March and April 2023, Pages 737-742

10.22092/ari.2022.359731.2466

Z Abdullateef Abdullah; L Fouad Ali


Increasing Efficacy of Covid-19 Vaccines by Lifestyle Interventions

Volume 77, Issue 5, September and October 2022, Pages 1527-1538

10.22092/ari.2021.356491.1854

A Gasmi; P Kumar Mujawdiya; S Noor; S Piscopo; S Résimont; A Menzel


Consecutive Hits of COVID-19 in India: The Mystery of Plummeting Cases and Current Scenario

Volume 76, Issue 5, November and December 2021, Pages 1165-1174

10.22092/ari.2021.356147.1791

T. K Suvvari; C P; S Kuppili; V Kandi; L. V. S Kutikuppala; V. D. K Kandula; S Mishra; A. K Sarangi; R. K Mohapatra; K Dhama